ENVISIA THERAPEUTICS
As many as 285 million people suffer from disease-related visual impairments and blindness1, but an estimated 80 percent of these visual impairments are actually preventable2. Unfortunately, the safety and effectiveness of many medical therapies for ocular disorders are limited due to poor drug uptake, non-specificity to target tissues, systemic side effects, or poor adherence to therapy. With a rapidly aging population, the unmet medical needs in ocular disease are becoming even more pronounced. As a result, patients and physicians are seeking improved ocular therapeutics that can significantly enhance patient outcomes and convenience.
ENVISIA THERAPEUTICS
Industry:
Biotechnology Health Care Medical Therapeutics
Founded:
2013-01-01
Address:
Morrisville, North Carolina, United States
Country:
United States
Website Url:
http://www.envisiatherapeutics.com
Total Employee:
11+
Status:
Closed
Contact:
(919)973-1440
Email Addresses:
[email protected]
Total Funding:
46.1 M USD
Technology used in webpage:
SPF Amazon New Relic Amazon Ohio Region NameBright
Current Employees Featured
Founder
Investors List
Canaan Partners
Canaan Partners investment in Series A - Envisia Therapeutics
Morningside Group
Morningside Group investment in Series A - Envisia Therapeutics
Pappas Ventures
Pappas Ventures investment in Series A - Envisia Therapeutics
Wakefield Group
Wakefield Group investment in Series A - Envisia Therapeutics
New Enterprise Associates
New Enterprise Associates investment in Series A - Envisia Therapeutics
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2014-09-10 | LQ3 Pharmaceuticals | Envisia Therapeutics investment in Series A - LQ3 Pharmaceuticals | 10 M USD |
Official Site Inspections
http://www.envisiatherapeutics.com
- Host name: ec2-3-19-116-195.us-east-2.compute.amazonaws.com
- IP address: 3.19.116.195
- Location: Columbus United States
- Latitude: 39.9653
- Longitude: -83.0235
- Metro Code: 535
- Timezone: America/New_York
- Postal: 43215
More informations about "Envisia Therapeutics"
Envisia Therapeutics Company Profile 2024: Valuation, …
Nov 19, 2017 Envisia Therapeutics General Information Description. Developer of a bio-research platform intended to focus on the development of novel ocular therapies. The company's platform uses its Particle Replication In Non …See details»
Envisia Therapeutics - VentureRadar
In 2013, Liquidia Technologies formed a new company, Envisia Therapeutics™, to develop novel therapeutics that can address critical unmet needs in ophthalmology. To address these critical …See details»
Company Information - RocketReach
Envisia Therapeutics, formed by Liquidia Technologies in 2013, is a privately held biotechnology company focused on the development of novel ocular therapies. Envisia is leveraging the …See details»
Envisia Therapeutics Inc - Company Profile and News
Company profile page for Envisia Therapeutics Inc including stock price, company news, executives, board members, and contact informationSee details»
Envisia Therapeutics Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Envisia Therapeutics Inc. of Durham, NC. Get the latest business insights from Dun & Bradstreet.See details»
Envisia Therapeutics - Craft
Envisia Therapeutics is a biotechnology company focused on the development of novel ocular therapies. It is leveraging the unique and powerful properties of the PRINT® platform to …See details»
Envisia Therapeutics Overview | SignalHire Company Profile
Envisia Therapeutics, formed by Liquidia Technologies in 2013, is a privately held biotechnology company focused on the development of novel ocular therapies. ... Organization Website: …See details»
Envisia Therapeutics - Products, Competitors, Financials, …
Envisia Therapeutics is a privately held biotechnology company with a focus on the development of novel ocular therapies. Use the CB Insights Platform to explore Envisia Therapeutics's full …See details»
Envisia Therapeutics - Crunchbase
Envisia Therapeutics is a biotechnology company focused on the research and development of novel ocular therapies. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. …See details»
Envisia Therapeutics - Company Profile - Tracxn
Nov 17, 2024 Envisia Therapeutics - Envisia Therapeutics is a biotechnology company focused on the research and development of novel ocular therapies. Raised a total funding of $39.7M …See details»
Envisia Therapeutics, Inc.:Company Profile & Technical Research ...
Envisia Therapeutics, Inc. is a company that provides Visual impairment, Pharmacy and Therapeutics, Drug uptake and more. Envisia Therapeutics, Inc. is headquartered in United …See details»
Envisia Therapeutics - Funding, Financials, Valuation & Investors
Envisia Therapeutics has a post-money valuation in the range of $100M to $500M as of Mar 23, 2016, according to PrivCo. Sign up for a free trial to view exact valuation and search …See details»
Envisia Therapeutics, Inc. - Drug pipelines, Patents ... - Patsnap
Explore Envisia Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, 23 news, Technology Platform:Monoclonal antibody, Drug:ENV-1305. ... The …See details»
IMPROVING OUTCOMES IN OPHTHALMOLOGY VIA SUSTAINED …
Envisia Therapeutics Dr Tomas Navratil Vice-President, Development Dr Benjamin Maynor Vice-President, Research Dr Benjamin Yerxa Chief Scientific Officer T: 919 973 1440 F: 919 973 …See details»
Envisia Therapeutics Careers and Employment | Indeed.com
Jan 5, 2016 Find out what works well at Envisia Therapeutics from the people who know best. Get the inside scoop on jobs, salaries, top office locations, and CEO insights. Compare pay for …See details»
Envisia Therapeutics - Pappas Capital
Envisia Therapeutics. ← Back to Ventures Portfolio. Envisia is a biotechnology company that licensed technology from Liquidia Technologies and is focused on the development of novel …See details»
Envisia Therapeutics - Contacts, Employees, Board Members
Organization. Envisia Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 1. About. …See details»
Envisia Therapeutics | OIS@AAO | Ophthalmology Innovation Source
Envisia Therapeutics This company, founded as a spin-out of Liquidia Technologies in 2013, began with a $25 million Series A, with the goal of developing the PRINT particle platform for …See details»
ENV-1305 - Drug Targets, Indications, Patents - Synapse
Last update 30 Nov 2024. ENV-1305. Last update 30 Nov 2024See details»